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SUMMARY 
This report describes the results of a collaborative study of an HPLC method for the coccidiostat 
narasin in five broiler feeds and one premixture. The collaborative study forms part of the EU-
project "Development and Validation of HPLC-methods for the official control of Coccidiostats and 
Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-2216). 
The principle of the method is as follows: Narasin is extracted using a mixture of methanol and 
phosphate buffer (90+10) with mechanical shaking. After dilution and filtration through a 
membrane filter, narasin is determined by reverse phase HPLC using post column derivatisation 
with dimethylaminobenzaldehyde (DMAB) in a solution containing sulphuric acid and detection at 
600 nm. 
The samples which were prepared for the collaborative study were 4 broiler feeds with declared 
narasin contents of 20, 45, 70 and 120 mg/kg, 1 blank broiler feed and 1 premixture with 
declared content of 1,2 % narasin. The feed samples were sent to the participants as blind 
duplicates, the premixture as a single sample. The participants were asked to do a single 
determination per sample for the feed samples and to analyse the premixture in duplicate. 
Results were reported by 13 laboratories. Statistical evaluation was performed according to ISO 
5725. 
The results of the collaborative study were evaluated in a meeting attended by the participants. 
It can be concluded that for feedingstuffs the repeatability and reproducibility of the method is 
acceptable. The results obtained for the recovery and for the blind blank sample are also 
satisfactory. The overall conclusion is that for feedingstuffs the performance of the method is 
satisfactory. 
For the premixture the rsdR (18,1 %) is far too high. According to the panel, a value of approx. 7 % 
for the rsdR of the premixture should be attainable. It was decided that for premixtures a new 
small-scale collaborative study will be organised (ca. 10 laboratories) with a modified method. 
Only a few laboratories have detected the factors D+l in some or all samples or standard 
solutions. This is a sound justification of the choice made in the method to quantify the narasin 
content in the samples on the basis of the factor A peak alone. 
Two laboratories used vanillin for post-column derivatisation. The results do not differ significantly 
from the results with DMAB (dimethylaminobenzaldehyde). The method description for 
feedingstuffs will be improved in several aspects. These modifications will not negatively affect 
the performance of the method. 
1 INTRODUCTION 
Within the framework of the EU-project "Development and Validation of HPLC-methods for the 
official control of Coccidiostats and Antibiotics used as Feed Additives (CAIMFAS-SMT4-CT98-
2216), a method was developed for narasin. Narasin is a coccidiostat which is registered for 
broiler feeds at contents of 40 - 50 or 60 - 70 mg/kg-
The method for feeds and premixtures was developed and validated by by LUFA - Augustenberg, 
Karlsruhe, Germany (see Final report on development and validation of a HPLC-method to 
determine narasin in feedstuffs, A. Thalmann, 29-10-1999). Subsequently, the method for feeds 
and premixtures was subjected to between-lab validation by the Danish Plant Directorate, Lyngby, 
Denmark (see report A. Pl0ger, 23-11-1999) and the State Laboratory, Dublin, Ireland (see report 
P. Shearan, January 2000) with satisfactory results (see Second Annual Report CANFAS, J. de 
Jong, 12-08-2000). 
Prior to the collaborative study, a kick-off meeting was organised (Brussels, 13-14/6/2000) and 
participating laboratories were given the opportunity to familiarise themselves with the method, 
using feed samples with stated contents of narasin. Also prior to the production of the materials 
for the collaborative study, separate batches of the materials were produced for stability testing, 
indicating that narasin is stable in feeds and premixtures at room temperature for 4 months. 
The samples which were prepared for the collaborative study were 4 broiler feeds with declared 
narasin contents of 20, 45, 70 and 120 mg/kg, 1 blank feed and 1 premixture with declared 
content of 1,2 % narasin. The feeds with 20 and 120 mg narasin per kg have been included in 
order to assure that the method is applicable for contents 2 times lower and 2 times higher than 
the permitted content. 
The feed samples were sent to the participants as blind duplicates, the premixture as a single 
sample. The participants were asked to do a single determination per sample for the feed 
samples and to analyse the premixture in duplicate. Before these samples were shipped, the 
between-sample homogeneity was checked with satisfactory results (see par. 3.1.2). 
Apart from the samples, a letter with instructions, reporting forms, etc. was sent to the 
participants (see Appendix 1). 
This report describes the results of the collaborative study. 
2 PARTICIPANTS 
The following laboratories/persons participated in the collaborative study. 
- Danish Plant Directorate, Lyngby, Denmark; A. Pl0ger, A. Kraemer-Peterson 
- IEEB, Bordeaux, France; J.P. Antalick, C. Fiette. 
- INETI/DTIA, Lisbon, Portugal; I. Felgueiras, R. Novo. 
- Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy; G. Biancotto, B. Allegretta, 
D. Berto, V. Capuzzo. ^ 
- Laboratory of the Government Chemist, Teddington, United Kingdom; G. Merson, J. Cowles, 
F. Lee. 
- LNIV, Lisbon, Portugal; J.M. Nunes da Costa, M.B. Casqueira. 
- LUFA-ITL Kiel, Kiel, Germany; F.H. Johannsen, Kollwitz 
- Masterlab, Putten, The Netherlands; K. van Schalm, B. Wolters 
- Plant Production Inspection Centre Agricultural Chemistry Department, Vantaa, Finland; R. 
Muhonen, T.Heikkinen 
- Rijksontledingslaboratorium, Tervuren, Belgium; K. Haustraete, A. Fontaine, M. Bral, R. van 
San. 
- RIKILT, Wageningen, The Netherlands; H.J. van der Kamp, H.C.H. Kleijnen. 
- Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA), Augustenberg, 
Germany; A. Thalmann, K. Wagner 
- State Laboratory Dublin, Ireland; P. Shearan, R. Reilly 
3 MATERIALS 
3.1 Samples for collaborative study 
3.1.1 Sample composition 
Specifications of the samples, which were produced for the collaborative study, are given in 
Table 1. 
Table 1 : Specifications of the samples 
Type of sample 
Broiler feed 
Broiler feed 
Broiler feed 
Broiler feed 
Premixture 
Declared 
content 
20 
45 
70 
120 
1,2 
Units 
mgAg 
mgAg 
mgAg 
mgAg 
% 
Subcontractor 
SDS-Trouw, Witham (UK) 
SDS-Trouw, Witham (UK) 
SDS-Trouw, Witham (UK) 
SDS-Trouw, Witham (UK) 
SDS-Trouw, Witham (UK) 
Date of 
production 
05/12/2000 
05/12/2000 
05/12/2000 
05/12/2000 
04/09/2000 
Mixing was completed at Special Diet Services (SDS) small-scale mixing facility. 
The main composition of the four feeds is given in Table 2. 
Table 2: Main composition of the four feeds 
^ " ^ • ^ ^ Product 
Ingredieru""—-^^^ 
Crude protein (%) 
Crude fat (%) 
Starch (%) 
Crude fibre (%) 
Crude ash (%) 
Moisture (%) 
Broiler feed 
18,3 
5 or 10* 
45,2 
4,1 
6,5 
8,7 
* see text 
The basic feed material contained 2,6% of crude fat. Fat was added up to 5% for the feeds with 
20 and 70 mg narasin per kg and up to 10% for the other two feeds containing 45 and 120 mg 
narasin per kg. The percentages of crude protein, starch, crude fibre and crude ash are 
calculated for the basic feed. 
The premixture was based on inorganic feed material and contained regular contents of 
vitamins, minerals and trace elements. The complete composition of the feeds and the 
premixture is stored in the files of the co-ordinator (confidential). 
The composition of the feeds and the premixture was the same as the composition of the 
products which were produced by SDS-Trouw in September 1999 for stability testing (see 
Report on homogeneity and stability of narasin, in broiler feeds and premix, A. Thalmann, LUFA-
Augustenberg, 27/06/2000). 
The feed products have been prepared in a quantity of 13 kg each. The 13 kg sack w^ as laid 
horizontally to allow removal of about 40 aliquots of 200 - 250 grams from the middle of the 
contents using a large plastic scoop. Each sample was taken as a single aliquot and transferred 
to a foil-lined paper sack which was then heat-sealed. The sacks were stored at room 
temperature prior to shipping to the participants. 
Next to the above mentioned samples which contained narasin, a blind blank feed was sent to 
the participants as well as a blank feed labelled "blank feed for narasin recovery purposes" (see 
Appendix 1). Both blank feeds concerned a broiler feed containing 2 mg/kg of virginiamycin 
(see the corresponding report) produced by IPC-Dier. This feed was analysed at LUFA 
Augustenberg prior to the collaborative studies and was found to contain no detectable amounts 
of narasin or interfering substances. 
3.1.2 Sample homogeneity 
The homogeneity of the samples was studied by LUFA Augustenberg by random selection of 10 
subsamples per feed or premixture, applying the HPLC-method developed in CANFAS (see Annex 
1 of Appendix 1). 
The results of the homogeneity determinations of the individual feeds are attached in Appendix 
2. Table 3 gives a summary of these results. 
Table 3: Results of homogeneity tests for narasin in four broiler feeds and one premixture 
N . Results 
Product \ s^ 
Broiler feed 
Broiler feed 
Broiler feed 
Broiler feed 
Premixture 
Declared 
content 
20 mg/kg 
45 mg/kg 
70 mg/kg 
120 mg/kg 
1,2% 
Measured 
content 
18,91 mg/kg 
41,56 mg/kg 
64,75 mg/kg 
114,76 mg/kg 
1,20% 
Homogeneity results 
Between 
sample CV (%) 
4,51 
2,84 
2,98 
1,04 
4,7 
Within sample 
CV (%) 
not determined 
n.d. 
n.d. 
n.d. 
3,9 
According to the Project Plan the CV's for homogeneity should not exceed 2 times the CV's for 
repeatability (CVhom < 2 CVr). Based on previous results of within-lab validation (see Second 
Annual Report CANFAS, J. de Jong, 12-08-2000) the maximum limit for CVhomwas set to 10 %. 
All between-sample CV's fulfil these requirements. Although for the feeds the within-sample CV 
was not determined it can reasonably be assumed that the within-sample variation is smaller 
than the between-sample variation. Thus, it is concluded that the samples are sufficiently 
homogeneous. 
3.1.3 Sample logistics 
The feed samples were sent as blind duplicates. The premixture was dispatched in foil-lined 
paper sacks each containing approximately 110 grams. The codes of the feed samples are 
given in Appendix 3. The samples were sent to the participants by courier service from Eli Lilly 
between February 12 and February 14, 2001. During transport no special precautions were 
taken with regards to the temperature of the samples. 
3.2 Reference standard 
The reference standard was supplied by Eli Lilly and Company together with the samples. The 
purity of the reference standard (Lot Nr. RS 0302) is 963 mg microbiological activity per mg on 
an "as is" basis. The certificate of analysis is described in Appendix 4. The participants were 
instructed to take note of the microbiological potency and the moisture content of the standard, 
(see Appendix 1). Later on (March 12, 2001) the participants were instructed by e-mail not to take 
note of the moisture content and to use the defined potency stated above. 
4 METHODS 
4.1 Method of analysis 
The method of analysis is included as annex 1 to Appendix 1. The participants were instructed 
that this method has to be used without any modifications. 
4.1.1. HPLC-conditions 
Various types of HPLC-columns were used (the column which is recommended in thejriethod is 
a Hypersil ODS C18, 250 x 4 mm Shandon, with a particle size of 4 urn). 
The mobile phase described in the method is a mixture of 900 ml methanol and 100 ml 
phosphate buffer pH 4. One laboratory used a different mobile phase. 
The HPLC conditions (Column and mobile phase) used by the participants are shown in Table 4. 
4.2 Method for statistical evaluation 
Statistical evaluation was performed according to ISO 5725 Part 2: Basic method for the 
determination of repeatability and reproducibility of a standard measurement method (First 
edition, 1994-12-15). 
The scrutinity of results for consistency and outliers was checked by 
a) Graphical consistency techniques: Mandel's h plot for between-laboratory variability, Mandel's 
k plot for within-laboratory variability 
b) Numerical outlier techniques: Cochran's test of the within-laboratory variability, Grubbs' test 
(single and double) for between-laboratory variability 
Whenever necessary and appropriate, laboratories which showed consistently high within-cell 
variation and/or extreme cell means across many levels and/or Cochran or Grubbs' outliers were 
contacted to try to ascertain the cause of the discrepant behaviour. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility of the method. The HORRAT ratios are given in Table 5. The HORRAT ratios should 
be lower than 2 (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). 
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Table 4: HPLC-conditions 
Partner 
11 
13 
23 
24 
26 
29 
30 
31 
32 
33 
35 
37 
41 
Column 
As described in the method 
As described in the method 
Not reported 
Spherisorb C18, 250x4,6 mm, 5 urn 
ODS-3, 10 urn 
Nova-Pak C18, 4,6x250 mm, 4 urn 
Kromasil C18, 150x4,6 mm 
As described in the method 
Waters Spherisorb S5 ODS-2, 250x4,6 
mm, 5 urn 
Hypersil ODS, 3 mm, 15 cm 
Chromspher C18, 200x3,0 mm 
Hypersil BDS C18, 250x4,6 mm, 5 urn 
As described in the method 
Mobile phase 
As described in the method 
As described in the method 
Not reported 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
Methanol : phosphate buffer = 97:3 (v/v) 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
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5 RESULTS 
For each participant the reported results for the samples, the completed questionnaire and 
representative chromatograms are annexed in Appendix 5. 
5.1 Statistical evaluation 
The results reported by the participants are given in Table 6. Figure 1 demonstrates thg Mandel h 
and k plots of these results. 
Statistical analysis of the results shows that lab 26 is a Cochran outlier for the 45 mgAg sample. 
The resulting values for the statistical parameters (mean, relative standard deviations for 
repeatability and reproducibility) are given in Table 6. According to the Project Plan, the rsdr-
values should be < 10 %. For all samples this criterion is met and consequently it can be 
concluded that the repeatability is satisfactory. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). The HORRAT ratios 
are given in Table 5. The HORRAT ratios should be lower than 2. For the four feed samples this 
criterion is met and established rsdR-values are in line with values predicted by the Horwitz 
equation. Consequently it can be concluded that the reproducibility of the method is satisfactory 
for the feed samples. For the premixture the HORRAT ratio is much higher than 2. 
Table 5: Horrat ratios of the Narasin collaborative study 
Mean after elimination 
of outliers1 (mgAg) 
18,12 
41,97 
64,62 
110,29 
10603 
Predicted 
rsdR 
10,345 
9,117 
8,543 
7,883 
3,965 
Established 
rsdR 
9,154 
7,284 
6,786 
6,086 
18,09 
Horrat2 
0,88 
0,80 
0,79 
0,77 
4,56 
Conclusion 
Reproducibility OK 
Reproducibility OK 
Reproducibility OK 
Reproducibility OK 
Reproducibility NOT OK 
1
 = lab 26/sample 45ppm 
2
 = Horrat is the ratio between the established rsdR and the predicted rsdR 
Lab 24 reported a value for the premixture which is about twice as low as the values reported by 
many other laboratories and which is recognised as a Grubbs' lower straggler. In order to exclude 
the possibility of a calculation error (e.g. a wrong dilution factor) this lab was contacted and 
replied that they were not able to find any mistake. Consequently this result is retained in the 
statistical evaluation. 
The Mandel h plot (see Figure 1) shows that lab 32 reports low results for all feed levels. This lab 
reported a recovery (82 %) that is lower than the mean recoveries of the other laboratories which 
are all 90 % or higher (see par. 5.3). Lab 32 was contacted to try to ascertain the cause of the 
12 
discrepant behaviour. Lab 32 indicated that the only possible reason could be the instability of the 
DMAB reagent. No problems were encountered with vanillin. While the recovery value of lab 32 is 
not a Grubbs' outlier (see par. 5.3) the results were not discarded from statistical evaluation. 
In the evaluation meeting the reason(s) why the HORRAT ratio for the premixture is too high were 
discussed. One possible reason could be that the premixture was already produced on 4 
September 2000. Decisions were made about how to proceed. The following options were 
regarded: 
- Redo the collaborative study for the premixture after modifications in the method. 
- Conclude that the method is not suitable for premixtures. 
- Accept the relatively high CVR for the premixture. 
The results of the discussions in the evaluation meeting are described in Chapter 6 of this report. 
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Table 6: Results reported by the participants 
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Figure 1: Mandel h and k plots of the results reported by the participants 
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5.2 Blank samples 
Table 7: Reported results of the participants for the blank samples 
Partner 
11 
13 
23 
24 
26 
29 
30 
31 
32* 
33 
35 
37 
41 
* Participa 
Blank sample 1 (mg/kg) 
ND 
<0,5 
<2 
0 
0,6 
0 
<5 
0 
Negative Negative 
Not found 
<1 
ND 
0 
nt 32 performed the analyses in duplical 
Blank sample 2 (mgAg) 
ND 
<0,5 
<2 
0 ± 
2,8 
0 
<5 
0 
Negative Negative 
Not found 
<1 
ND 
0 
te 
One lab (nr. 26) detected small signals in the blind blank samples above the limit of quantification, 
which was estimated at 0,5 mgAg by lab 26. The other laboratories did not detect signals in the 
blind blank samples. 
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5.3 Recoveries 
Table 8: Recoveries 
Partner 
11 
13 
23 
24 
26 
29 
30 
31 
32 
33 
35 
37 
41 
Recovery 1 in % 
106 
97 
Not reported 
94 (level 12,5 mgAg) 
91 
101 
98 
99 
82 
98 
94 
89 
106 
Recovery 2 in % 
97 
97 
Not reported 
92 
102 
82 
95 
90 
103 
recovery average in % 
102 
97 
Not reported 
94* 
92 
101 
98 
101 
82 
98 
95 
90 
104 
* Laboratory 24 also reported a recovery of 77% at a level of 5 mgAg- This value is not taken 
into account because this level is too low. 
Only lab 32 reported recoveries lower than 90%, viz. 82%. In task 1 and 2 of the project (within-
and between-lab validation) recoveries of 86% and higher were measured. According to ISO 5725 
the mean recovery of lab 32 (82%) is not a Grubbs' outlier. 
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5.4 Remarks 
Table 9: Remarks made by the partners 
Partner Remarks 
11 The meaning of 8.1 - Let stand over night - is not clear. 
13 No remarks 
23 Not reported 
24 The available post-column reactor was equipped with a single pump; the coil was 3 m 
long; reaction temperature was fixed at 95 °C. Reactant flow rate was 0,4 ml/min. 
26 1) Paragraph 4.1.3 is a little confusing because it refers to two temperatures. The 
reference to 95°C would be better amended to 90°C. 
2) Paragraph 5.2 needs some editing. It is not very often that an analyst knows the level 
of the drug additive in a feedingstuff. It would be better if a definite weight was specified 
and the concentration determined by subsequent dilutions of the extract. 
3) We found it necessary to have a significant length of tubing between the end of the 
reaction coil and the detector. This was to allow the mobile phase, which is 
predominantly methanol, to cool down and minimise the risk of bubbles entering the 
detector flow cell. This is the same problem as was encountered with the maduramycin 
trial. Even with this tubing present, which was between 2 and 3 metres in length we still 
experienced the occasional electronic spike which we have assigned to a bubble 
entering the flow cell. 
4) Paragraph 5.2 we do not consider it good practice to recommend taking such small 
test portions of feed for this type of analysis. This will increase the uncertainty and 
imprecision of the analytical method significantly depending on the homogeneity of the 
sample. If a 20g test portion is taken these parameters can be reduced. 
5) It is our opinion that the calibrant range described in paragraph 5.4.2 needs a 
complete revision. The organisers advised us that the concentration of narasin in the 
samples was in the range 10 mgAg to 150 mgAg- This meant that by following the 
extraction procedure as written and by taking a 20 g test portion of sample the 
concentration of narasin in the final extract was 2.0ug/ml. This concentration is 
equivalent to the level of the top calibrant standard. This means that we would have had 
to have injected all the samples extracts twice or at worse we would have had to re-
extract them a second time because the run time for this study was some 24 hours and 
the method gives no indication of the extract stability. We in fact produced a linear 
calibration curve between 0.4 ug/ml and 12.25 ug/ml and with the equipment that we 
used believe that 0.4 ug/ml is the lowest standard that we could realistically work with. 
6) We found the sample extraction procedure generally simple and easy to follow. 
7) We, in fact, used the option to pump the post column reagent separately (i.e. we used 
three pumps). 
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Partner 
29 
30 
31 
32 
33 
35 
37 
41 
Remarks 
- We repeated the analysis, as we discovered that our DMAB reagent wasn't very good, 
and we used a new one. So the standards had a greater area and a better correlation. 
- Only samples 293384 and 293489 were not injected again as they were the blind blank 
duplicates of feed samples sent. 
- The dilution factors applied this time were decided, as we knew now which samples 
were the duplicates and their contents. 
1) Usually for narasin determination we use vanillin reaction and not buffered mobile 
phase. The response is twice better. 
2) Concentrations of calibration solutions are too low and peak area small. This 
increases the error of area measurement. 
Calibration curve adjusted to: 0,5 -1,0 - 2,5 - 5,0 -10,0 ug/ml. 
All samples have been diluted by a factor of 3 before injection. 
The reagents 3.13 (methanol + sulphuric acid) and 3.14 (DMAB solution) were mixed 
before HPLC analysis. The flow rate of the mixture for post column derivatisation was 
0,8 ml/min. 
No remarks 
We used one reagent pump at flow 0,8 ml/min. 
The flow of the mobile phase was 0,7 ml/min 
1 have presented a number of combinations of results to you (in the order in which the 
extracts were analysed) 
A) The sample extracts were analysed initially as blind samples (unknown) and therefore 
run undiluted vs. the calibration curve as outlined in method (the spike of 50 ug/kg was 
diluted within calibration range and the premixture was also diluted). As most of the 
extracts contain narasin (outside the calibration range) - Are they valid data? 
2 approaches were taken: 
B) Prepare a calibration curve 10 fold greater and run extracts undiluted. 
C) Dilute extracts 10 fold within calibration range as outlined in method. 
Remarks 
- Introducing dilutions introduces possible further errors. 
- Introducing dilutions introduces loss of sensitivity with respect to factor D/l. 
NOTE: after consultation of the co-ordinator it was agreed to use the results obtained 
with option C in the statistical evaluation because option C follows the method most 
strictly. 
No remarks 
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5.5 Narasin factors D+l 
Participants were asked to supply information about detection of the D and I factors in narasin, 
see Annex 5 of appendix 1. 
The results are summarised in Table 10. 
Table 10: Results for factors D+l 
Lab nr. 
11 
13 
23 
24 
26 
29 
30 
31 
32 
33 
35 
37 
41 
Information on factors D+l ^ 
ND* 
ND 
Not reported 
ND 
ND 
Only detected in the standard solution of 25 ug/ml 
ND 
ND 
Not detectable in most of the samples 
Detected in standard, premixture, and feed samples 333478, 333392, 
333396, 333485, 333497 
Not detected in feed samples 333381, 333491, 333451, 333476, 333459 
ND 
Only in undiluted extracts factors D+l appeared in samples >60 mg/kg (see 
chromatograms); factors are not noted in 1 ug/ml standard solution. 
D+l detected in all positive samples 
* ND means that factors D+l are not detectable in the samples and the standard solutions. 
Only a few laboratories have detected the factors D+l in some or all samples or standard 
solutions. This is a sound justification of the choice made in the method to quantify the narasin 
content in the samples on the basis of the factor A peak alone. 
5.6 Special Request 1: post-column derivatisation with vanillin 
The following partners performed the post-column derivatisation with vanillin: 
- Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA), Augustenberg, 
Germany; A. Thalmann, K. Wagner 
- LNIV, Lisbon, Portugal; J.M. Nunes da Costa, M.B. Casqueira. 
- Plant Production Inspection Centre Agricultural Chemistry Department, Vantaa, Finland; R. 
Muhonen, T.Heikkinen 
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5.6.1 HPLC conditions 
Table 11: HPLC conditions 
Partner 
LUFA, Augustenberg, 
Germany 
LNIV, Lisbon, Portugal 
Plant Production Inspection 
Centre Agricultural 
Chemistry Department, 
Vantaa, Finland 
HPLC column 
Not reported 
Same as normal method 
Same as normal method 
Mobile phase 
Not reported 
Same as normal method 
Same as normal method 
5.6.2 Recoveries 
Table 12: Recoveries 
Partner 
LUFA, Augustenberg, 
Germany* 
LNIV, Lisbon, Portugal 
Plant Production 
Inspection Centre 
Agricultural Chemistry 
Department, Vantaa, 
Finland 
Recovery 1 in % 
Not reported 
100 
81 
Recovery 2 in % 
100 
Average recovery in 
% 
100 
81 
recovery compared with normal extraction procedure 
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5.6.3 Results of the samples 
Table 13: Results of the samples that were derivatised with vanillin 
Partner 
Sample content 
(mgAg) 
0 
0 
20 
20 
45 
45 
70 
70 
120 
120 
Premixture 
LUFA 
Augustenberg, 
Germany 
Results (mgAg) 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
Not reported 
LNIV, Lisbon, Portugal 
Result 1 
(mgAg) 
Negative 
Negative 
18,74 
18,17 
41,35 
43,44 
68,73 
63,95 
114,83 
108,39 
10932,8 
Result 2 
(mgAg) 
Negative 
Negative 
18,58 
18,34 
40,4 
43,21 
68,82 
62,2 
115,28 
107,21 
11013,55 
Plant Production 
Inspection Centre 
Agricultural Chemistry 
Department, Vantaa, 
Finland ^ 
Results (mgAg) 
0 
0 
19,4 
18,6 
43,1 
47,1 
72,4 
75,7 
118,7 
124,8 
10.962-11.164 
The values do not differ significantly from the mean values obtained with DMAB (see par. 5.1) 
5.6.4 Remarks 
Table 14: Remarks made by the partners 
Partner 
LUFA, Augustenberg, Germany 
LNIV, Lisbon, Portugal 
Plant Production Inspection Centre Agricultural 
Chemistry Department 
Remarks 
area monensin equal to monensin with DMAB 
area narasin < 30% less than with DMAB 
salinomycine <30% less than with DMAB 
Vanillin solution stable ~ 1 day 
No remarks 
Reactor temperature was 90°C 
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5.7 Special request 2: extraction overnight 
The following partners performed the extraction overnight: 
- Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA), Augustenberg, 
Germany; A. Thalmann, K. Wagner 
- LNIV, Lisbon, Portugal; J.M. Nunes da Costa, M.B. Casqueira. 
5.7.1 HPLC conditions 
Table 15: HPLC conditions 
Partner 
LUFA, Augustenberg, 
Germany 
LNIV, Lisbon, Portugal 
HPLC column 
Not reported 
Same as normal method 
Mobile phase 
Not reported 
Same as normal method 
5.7.2 Recoveries 
Table 16: Recoveries 
Partner 
LUFA, Augustenberg, 
Germany* 
LNIV, Lisbon, Portugal 
Recovery 1 in % 
+ 1,06% 
93 
Recovery 2 in % 
+ 1,01% 
90 
Average recovery in 
% 
1,04% 
92 
* recovery compared with normal extraction procedure 
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5.7.3 Results of the samples 
Table 17: Results of the samples that were extracted overnight 
Partner 
Sample content 
(mgAg) 
0 
0 
20 
20 
45 
45 
70 
70 
120 
120 
Premixture 
LUFA, Augustenberg, Germany 
Result compared with normal 
extraction procedure 
Not reported 
Not reported 
-1,4% 
- 4,2% 
Not reported 
Not reported 
Not reported 
Not reported 
-2 ,1% 
- 0,9% 
Not reported 
LNIV, Lisbon, Portugal 
Result 1 (mgAg) 
negative 
negative 
17,34 
17,46 
38,07 
40,45 
62,43 
58,47 
106,24 
102,85 
11121,04 
Result 2 (mgAg) 
Negative 
Negative 
17,60 
16,81 
39,45 
38,77 
63,15 
58,00 
104,42 
101,93 
10395,38 
The values seem to be slightly lower than those obtained with the normal extraction procedure. 
However, these data are far from sufficient to draw firm conclusions. In the evaluation meeting it 
has been discussed whether the possibility of overnight extraction is left open (see Chapter 6). 
5.7.4 Remarks 
Table 18: Remarks made by the partners 
Partner 
LUFA, Augustenberg, 
Germany 
LNIV, Lisbon, Portugal 
Remarks 
Experiences from other trials: there are mineral feeds where the 
contents in polyether antibiotics is lowered by > 20% overnight 
Conclusion of German working group: if a figure results with 
overnight extraction that does not match the declared value, the 
analyses have to be repeated with extraction for 1 hour. 
No remarks 
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5.8 Special requests 3: microbiological analysis 
The following partners performed the microbiological analyses of the samples: 
- Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA), Augustenberg, 
Germany; A. Thalmann, K. Wagner 
- Rijksontledingslaboratorium, Tervuren, Belgium; K. Haustraete, A. Fontaine, M. Bral, R. van 
San 
5.8.1 Recoveries 
Both partners did not report recoveries. 
5.8.2 Results of the samples 
Table 19: Reported results of the samples analysed with the microbiological method 
Partner 
Sample content 
(mgAg) 
0 
0 
20 
20 
45 
45 
70 
70 
120 
120 
Premixture 
LUFA, Augustenberg, Germany Rijksontledingslaboratorium (ROD, 
Tervuren, Belgium 
Reported microbiological activity (in mg/kg) 
Not reported 
Not reported 
Not detectable 
Not detectable 
33,0 
33,2 
62,5 
65,5 
102,9 
109,3 
10195 
Not found 
Not found 
20,0 
19,3 
43,5 
44,0 
67,4 
66,4 
120 
119 
10653 10805 
The values for the feeds obtained by ROL are slightly higher than the mean values obtained with 
the CANFAS-method (and in very good agreement with the declared values) while the values for 
the premixture are similar to the mean values reported with the CANFAS-method. 
The values reported by LUFA Augustenberg are slightly lower than the mean values obtained 
with the CANFAS-method, especially at lower contents. For the 20 mg/kg sample narasin is not 
detected at all. 
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5.8.3 Remarks 
Table 20: Remarks made by the partners 
Partner 
Staatliche Landwirtschaftliche 
Untersuchungs- und Forschungsanstalt 
(LUFA), Augustenberg, Germany 
Rijksontledingslaboratorium, Tervuren, 
Belgium 
Remarks 
Method: Official method for monensin (agar 
diffusion) 
No remarks 
26 
6 EVALUATION AND CONCLUSIONS 
The results of the collaborative study were evaluated in a meeting in Tervuren (Belgium) on June 
19-20,2001. 
The relatively low values for all feed samples and for the recovery reported by lab 32 were 
discussed. Lab 32 indicated that the only possible reason could be the instability of the DMAB 
reagent. No problems were encountered with vanillin. While the recovery value of lab 32 is not a 
Grubbs outlier, the panel decided that the results of lab 32 should be taken into account in the 
statistical evaluation. 
The results of the statistical evaluation, as described in par. 5.1, Table 6 have been accepted by 
the panel. 
Consequently it can be concluded that for feedingstuffs the repeatability and reproducibility of the 
method is acceptable. The results obtained for the recovery and for the blind blank samples are 
also satisfactory. The overall conclusion is that for feedingstuffs the performance of the method is 
satisfactory. 
The results (baseline noise) obtained by a number of laboratories and the remarks made by some 
laboratories indicate that the calibration curve should be shifted to a higher range. This will be 
changed in the method. 
For the premixture the rsdR (18,1 %) is far too high. Although not an outlier, lab 24 largely 
contributes to the unsatisfactory repeatability. Lab 24 will repeat the analysis and also send the 
sample to Thalmann. Lab 26 used a sample weight of 0,2 g for the premixture. This can possibly 
contribute to the low results of this lab. According to the panel, a value of approx. 7 % for the rsdR 
of the premixture should be attainable. It was decided that for premixtures a new small-scale 
collaborative study will be organised (ca. 10 laboratories) with a modified method. The 
modifications in the method are as follows: 
- weight is increased to 5 g 
- the calibration curve will be shifted to higher concentrations (see above) 
- more strict description of the calibration method, stating that the concentration of the 
premixture extract should be in the middle of the calibration curve 
- the mixing of the premixture prior to the weighing of the 5 g will be described more strictly 
(see instructions for nicarbazin) 
- the extraction time will be fixed to 1 hour (the extraction overnight will become optional and 
will be described in the remarks) 
The panel agreed with the conclusion (see par. 5.5 of this report) that quantification should be 
based on the factor A peak only. 
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The following remarks, related to the method description have been accepted: 
- lab 11: in par. 8.1 "at room temperature" will be added in the text 
- lab 26, remark 1 
- lab 26, remark 2, par. 5.2: it will be considered to define a minimum weight for feeds and to 
describe separate procedures for feeds and premixtures, like in other methods (e.g. 
nicarbazin). 
- lab 26, remark 5; however, it is important to describe or to be sure that the sample extracts 
are always diluted by a factor of 3 or more. 
- The use of stainless steel tubing in the post-column reactor and detector shoujd be avoided 
- A remark will be added about the suitability of vanillin for post-column derivatisation, stating 
that a full validation with vanillin has not been performed 
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APPENDIX 1 
Letter with instructions, sent with the samples (with five annexes) 
cc. Driessen, Van der Kanw<^deJopg 
to addressee 
4, 
Dear colleague, 
With separate post the samples for the collaborative study for narasin will be sent to you 
by Mr. Towell {Eli Lilly). We expect the samples will be sent to you this week. You will 
receive the following samples : 
• 10 feed samples, with the text "additive: NARASIN" and with a sample code; these 
samples constitute 4 blind duplicates of feed samples containing narasin (contents 
in the range between 10 and 150 mg/kg) and 1 blind duplicate of a blank feed 
• 1 premixture containing narasin, content in the range between 0,5 and 3 %. 
DATE 
13 Fabruary 2001 
SUBJECT 
Collaborative itudy CANFAS 
narasin 
ENCLOSURE») 
6 
OUR REFERENCE 
Ol/0004565/rik/rlkjjo 
HANDLED BY 
Dr. J. da Jong 
DIRECT ITELERHONE) LINE 
•31 317 47 55 81 
EMAIL 
j.dajongORIKILT.WAG-UR.nl 
For the feed samples you are asked to do a single determination per sample, the 
premixture must be analysed In duplicate. 
For recovery purposes, a blank sample, with the text "blank feed for narasin recovery 
purposes" will be included. 
The method which has to be used is included as Annex 1 (please note that this method is 
a modified'version of the method which was distributed prior to the kick-off meeting). 
Annex 2 contains the reporting form. This form has already been send to you by E-mail 
as an Excel 5.0 file. We strongly prefer to get the results back in electronic form by E-
mail (please send the results to the following E-mail address: j.j.m.driessen@rikilt.wag-
ur.nl). Of course you can also fill in the form and send it by fax or normal mail. 
The deadline for reporting the results is 13 April 2001. This deadline is shorter than 
for the other analytes because we want to organise the evaluation meeting for all the 
analytes before the summer. Hopefully, it is not a problem for you to stick to this 
deadline. 
RIKILT 
Stat* Institute for Quality 
Control of Agricultural 
Product* 
P.O.Box 230 
6700 AB Waganingan 
Tha Netherlands 
VISITOR!' ADDRESS 
Building no. 123 
Bornaattaag 45 
6708 PD Waganingan 
TELEPHONE 
+31 317 47 54 00 
FAX 
+31 317 41 77 17 
CHAMBER OF COMMERCE REGISTRATION NO' 
09098104 ta Arnham 
THE INTERNET 
«rww.rikllt.waganlngan-ur.nl 
Annex 3 contains instructions for handling (milling, storage) of the samples. 
Annex 4 is a questionnaire. We kindly ask you to give us information about the 
experimental conditions, recoveries, etc.. On this form you can also give your remarks 
about the method. 
Annex 5 is a second questionnaire regarding the factors of narasin. 
INSCRIBED IN THE STERLAB REGISTER OF LABORATORIES UNDER HO. L170 FOR AREAS DESCRIBED IN DETAIL IN THE ACCREDITATION 
Annex 6 contains information about special requests. We hope that, next to the regular 
determinations, you are prepared to volunteer to do some extra work. 
The reference standard of narasin which has to be used will be send to you by mr. Towell 
(Eli Lilly), together with the samples. Please take note of the microbiological potency and 
the moisture content of this reference standard (see Annex 5). 
We wish you and your colleagues the best with the collaborative studies. If you have any 
questions, do not hesitate to contact us. 
Kind regards, 
dr. Jacob de Jong ing. J.J.M. Driessen 
CANFAS coordinator coordinator CANFAS collaborative 
studies " ,K,L* 
Stat* Institut« for Quality Contr 
of Agricultural Products 
DATE 
13 February 2001 
OU« REFERENCE 
c c 01/0004565/rlk/rlkjJo 
Mrs. D. Bennink, European Commission, DG Research, CII/3, Brussels ^
 2 
Mr. D. Towell, Eli Lilly and Company Ltd., Speke Operations, Liverpool 
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CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 1 - Description of the method 
CANFAS/NAR/09102000/A.THALMANN 
Determination of Narasin with High Performance Liquid Chromatography (HPLQ 
1 Scope 
The method serves for the quantitative determination of Narasin sodium in 
S S ! p r e m i x t u r e s and concentrates. THe limit of détermination is 20 mg/kg, the 
limit of detection 1 mg/kg. 
2 Principle 
Narasin is extracted using a mixture of methanol and phosphate buffer (90+10) with 
S a n t e a l shaking. After dilution and filtration through a membrane filter narasin is 
determined by reverse phase HPLC using post column der iva t ion ™th 
d^^aminobenzaldehyde in a solution containing sulphuric acid and detection at 
600 nm. 
3 Reagents 
3.1 Methanol - HPLC grade 
3 2 di-tK)tassiunmydrogermhospbÄte,waterrree 
33 di-potassiumhydrogenphosphate solution, c CCHPOJ « 0.05 mol/1 water 
3 4 Potassiumdihydrogenphosphate,wateriree 
3 5 Potassiumdihydrogenphosphate solution, c (KH,P04) - 0.01 mol/1 water 
3.6 1,5-dimetoymexylamine (6-methyl-2-heptylamme, C,H19N) 
3 7 Ortho-phosphoric acid, w (H3P04) «• 85 % 
3^ 8 Sulphuric acid, w (HaSCv) = 95-97 * 
3 9 4-(dimemylamino>benzaldehyde (DMAB, GAi"UJ 
110 Extraction solvent: 900 ml methanol (3.1) are mixed mth 100 ml di-
notassiumhydrogenphosphate solution (3.3). ^ « - « , 
111 PWhRte buffer To 500 ml solution of potassiumdihydrogenphosphate (3.5) 3.0 ml 
S ^ o r i c l L T d (3 7\and 10.0 ml 1,5-dimemymexylamine (3.6) are added. Hie pH 
3 12 ÏÏwaïL WOirim 
. 1. Ml^ol-sulphuric acid: 40 ml sulphuric acid (3.8) are given cautiously while 
314
 SÄSS^^ 
during 15 min. 
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3.15 
3.16 
4.1.1 
4.1.2 
4.1.3 
4.1.4 
4.1.5 
Narasin-sodium reference standard (monocarboxylic acid-polyether-sodium salt, 
C43H7,NaOn) with defined microbiological activity and factor composition. 
Narasin-stock solution, 250 ug/ml 
An amount of narasin-sodium (3.15) equivalent to 25.00 mg microbiological activity 
is solved in 100 ml methanol (3.1). The solution is stable for 4 weeks if kept at >0 - < 
10 °C. 
4 Apparatus J set he*wtf* 8-4 
4.1 HPLC-system consisting of: / 
Pump - pulse free, flow capacity 0.1-2.0 ml/min / 
Injection system, manual or autosampler with loop suitabWfor 100 ul injections 
Post-column reactor (double pump or two single pumpsÄwith mixing chamber, 
reaction coil of inert material (f.e. Teflon or Peek) for operation at 95 °C, 7.0 m with 
0.33 mm ID and water bath or reactor oven for operation at 90 °C 
VIS-detector, variable wavelength, suitable for measurements at the wavelength of 
600 nm 
Analytical column - 4 um Cl8 Hypersil ODS, 250 x 4 mm f.e. Shandon or 
equivalent (8.2) 
4.2 Magnetic stirrer or mechanical shaker 
4.3 Ultrasonic water bath 
4.4 Membrane filter of Teflon, pore diameter 0.45 um 
4.5 Commercially available equipment 
5 Procedure 
5.1 General 
5.1.1 Blank feed 
For the performance of the recovery test (5.1.2) a blank feed should be analysed to 
check that neither Narasin nor interfering substances are present. The blank feed 
should be similar in type to that of the sample and Narasin or interfering substances 
should not be detected. 
5.1.2 Recovery test 
A recovery test should be carried out by analysing the blank feed which has been 
fortified by addition of a quantity of Narasin, similar to that present in the sample. To 
fortify at a level of 50 mg/kg transfer 4 ml of the stock solution (3.16) to a conical 
flask and evaporate the solution to approximately 0.5 ml. Add 20 g of the blank feed, 
mix thoroughly and leave for 10 minutes mixing again several times before 
processing with the extraction step (5.2). 
Alternatively, if a blank feed similar in type to that of the sample is not available 
(5.1.1), a recovery test can be performed by means of the standard addition method. 
In this case, the sample to be analysed is fortified with a quantity of Narasin similar 
to that already present in the sample. This sample is analysed together with the 
unfortified sample and the recovery can be calculated by subtraction. 
5.2 Extraction 
Depending on the concentration expected 0.200-20.0 g are weighed into a 250-ml-
Erlenmeyer flask, 100 ml extraction solvent (3.10) added, treated 5 min in the 
Ultrasonic water bath and stirred on a magnetic stirrer or shaken on a mechanical 
shaker (4.2) for at least 1 h. Let settle the coarse particles. If necessary an aliquot is 
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diluted to 1.0 ng/ml with mobile phase (3.12) and filtered through a membrane filter 
(4.4). 
5 3
 ^foUo^nt^nditions are offered for guidance, other conditions may be used 
nrovided that they give equivalent results. 
concentration measured after post-column reaction (4.1.3) mth a UV-Detector 
(â 1 41 at 600 nm. . , 
A ahauot of the sample solution (5.2), f.e. 100 ul is injected on tiie séparation 
LtZmâNetted with the mobile phase (3.12). The mean heights of the peaks resp. 
S S 5 sevSl injections of the calibration solutions (5.4.2) are measured. 
OTT ^-conditions 
Hypersil ODS, 250 x 4 mm, 5 um 
Column (4.1.5) Mixture of900 ml methanol (3.1) 
Mobile phase (3.12)
 + 100^phOSphate buffer (3.11) 
* u-i « u « 0.7ml/min 
Flow rate of mobile phase . 
Flow rate ofmethanol-sulphuric acid-mixture (3.13) 0.4mtan 
Flow rate of DMAB-solution (3.14) 0-4 ml/mm 
Temperature of the post-column reaction w <-
VIS-Detectorafterpost-columnreaction oOOnm 
. 100 ul 
Volume of injections height or area of peak 
Calculation 
5 A 1
 S Ä e^tractionsolvent (3.10) to 50 ml. The concentration£ narasm^ 
ritm* w - 25 ug/ml. The solution is stable for 4 weeks if kept at >0 - < 10 C. 
Preoaration of the calibration solution: 1.0,2.0,4.0 and 8.0 ml of the woridng 
^ d X l u t i ^ 
^ m o b i l e phase (3.12) and mixed. The concentration of narasin-sodium 
corresponds to ~ 0.25,0.50,1.00 and 2.00 ug/ml. 
The calibration solutions have to be prepared daily. 
5 4 3 Preparation of the calibration curve 
IMul each of the calibration solutions (5.4.2) are injected and the mean height or 
retention time of narasin is approximately 19 mm. 
6 Calculation ; - , . , . , ^ •«. 
^ ^rinn of narasm-sodium is calculated in mg/kg microbiological activity 
The « i f » ^ * * " £
 offce peak of factor A in sample solution (5.3) and the 
i ^ Ä « S Ï A is the same in the feed additive and in the^andard. 
rtcontentwinthe sample is calculated from the concentration received respecting 
^ T d l t i o n by nJans of the following formula: 
5.4.2 
Page 4 of5 
V * b * F 
w = mg/kg. 
V = volume of extractant in ml (100 ml see 5.2) 
b - concentration of the sample solution in ug/ml microbiological^ activity of narasin-
sodium 
E » weigh of the sample in g 
F - factor of dilution 
7 Statistics 
(Will follow) 
8 Remarks 
8.1 Extraction 
Due to the addition of di-potassiumhydrogenphosphate to the extractant solvent it is 
possible to let stand the extracts over night with most of the samples. Since it may 
occur - especially in premixtures and mineral feeds - that there is a slight breakdown 
of narasin the analysis has to be repeated with shaking of the extract for not more 
than 1 hour before chromatography. 
In a few feedstuffs it was observed that unknown compounds interfered with the 
retention time and peak shape in chromatograms when low concentrations (< 20 
mg/kg) of narasin were present. To overcome this difficulty 10 g of Alumina 90 
(Merck 1.01097 or equivalent) were added to the weigh. 
If interfering pharmaceutical agents are present the following procedure is applied: 
Weigh 20.0 g sample into 250 ml Erlenmeyer flask. Add 100 ml hexane, stopper and 
shake for at least one hour on a wrist-action shaker. Filter sample solutions through 
42 Whatman filter or equivalent into 125-ml-Erlenmeyer flask. Pipet 20.0 ml of 
extract and evaporate to dryness on the nitrogen evaporator. Dissolve the residue in 
20.0 ml of extraction solvent. Introduce this solution into a prepared column with 10 
g Alumina 90. Filter a portion of the eluate before proceeding to the HPLC analysis. 
8.2 Separation material 
Baseline separation between narasin factor A and salinomycin must be obtained. 
Hypersil ODS 5 mm in a 250 x 4 mm steel column has been proven as the best one. 
It is possible to separate narasin from other polyether antibiotics and to get the peaks 
of the 4 main factors. Inertsil and Purospher can be recommended if there is doubt 
whether narasin is separated from other compounds. The retention times are longer 
than with Hypersil. 
8.3 Protection against corrosion 
All fittings, which come in contact to the methanol-sulphuric acid-mixture (3.13), 
should be made from Teflon, Peek or comparable material. 
8.4 Post-column reaction 
If only one pump for the post-column reaction is available the reagents 3.13 and 3.14 
may be mixed. Since DMAB undergoes quick auto-oxidation resulting in darkening 
Page 5 of 5 
of the solution this has to be kept protected from light in an ice bath and has to be 
used within 24 h. 
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Annex 3 - Instructions for handling of the samples 
1. Storage 
Store the samples at room temperature until analysis. Protect the samples from light. 
?.. Milling (see, par. 5.1) 
• Feed samples: grind the feed samples with a mill equipped with a 1 mm screen 
• Premix: premix samples should not be milled 
3. Mixing of the test samples before weighing (see par, fi.1) 
Mix the entire sample thoroughly 
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Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: , 
f^rnmatngraphir conditions: 
• Column: 
• D As described in the method 
• D Other: 
• Mobile phase: 
• a As described in the method 
• D Other: 
• Flow-rate: m(/min 
• Injection volume: ul 
Chromatograms: Please include representative chromatoyrams of: 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/I peak, see Annex 5) with an arrow 
RftcnvBry results; 
• Percentage recovery: % 
• Single/duplicate determinations: D single a duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mgAg 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4, page 2 
Remarks /Cqrnmpnts (if nenessarv. continue on another page) : 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. JJ.M. Driessen 
RIWLT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax +31-317417717 
Thank you for your cooperation I 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 5 - Questionnaire 2 (narasin factors) 
Laboratory: 
Contact person: 
Sample code: (please complete one annex for each sample) 
Weigh standard: 
Microbiological activity standard: 
Moisture content standard: 
Concentration of the stock standard solution (in microbiological activity): 
Dilution standard: 
Weigh sample: 
Dilution sample: 
The concentration of narasin is calculated from the peak of factor A (see paragraph 6 of the method). However, 
we ask you to give information on the area of the peaks of the factors D and I as well (the peaks of factors D 
and I are indicated in the chromatogram attached). If you cannot detect the peaks of these factors in the 
standards or samples, please indicate with ND (= non detected). 
Factor A retention time (min) 
Standard* 
Sample 
Factor A peak height or area 
Standard I...ying/ml)Je 
Sample 
Content determined via factor A 
Factor D +1 peak area (combined) 
Standard [.../(ng/ml)]d 
Sample 
Height/area" 
Area 
•give the range of retention times for the calibration solutions 
•indicate if you measured peak height or area 
'give the mean peak height/ area for the calibration solution containing 1 ng/ml, as derived from the calibration 
curves 
"give the mean peak area for the calibration solution containing 1 ng/ml, as derived from the calibration curves 
CANFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 - NARASIN 
Annex 5, page 2 
Remarks /Comments (if necessary, continue on another page) : 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. J.J.M. Driessen 
RIWLT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax+31-317417717 
Thank you for your cooperation I 
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Annex 6 - Special requests 
Volunteers are asked to do the following additional work: 
• post-column reaction with vanilL(see page 2 of this annex) 
• extraction: overnighi (see par. 5.2) 
• use of a microbiological method (please indicate which method and add a description) 
Please report the results in a copy of annex 4 and clearly describe your modification, conditions, etc. 
Please also include representative chromatograms. 
Thanks in advance for doing the additional work 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 6, page 2 - Special requests 
Conditions for post-column derivatisation with vanillin 
Vanillin * 98% (HPLC) 
• 
• 
Methanol, HPLC-grade 
• Sulfuric acid, 95-97%, p.a. 
• Vanillin reagent 
Dissolve 10 g of vanillin in a mixture of 250 ml of methanol and 5.0 ml of sulfuric acid. Mix well and 
sonicate for some min under vacuum at room temperature. This solution has to be prepared daily 
prior to use and has to be cooled with ice water during use. 
• Row rate reagent pump: 0.8 m|/min 
• Reactor temperature: 95°C 
• Detection wavelength: 520 nm 
Other conditions are not changed 
APPENDIX 2 
Homogeneity of samples 
Narasin collaborative study Homogeneity 05.02.2001 
Sample No 
133011 
133012 
133013 
133014 
133015 
133016 
133017 
133018 
133019 
133020 
133021 
133022 
133023 
133024 
133025 
133026 
133027 
133028 
133029 
133030 
133031 
133032 
133033 
133034 
133035 
133036 
133037 
133038 
133039 
133040 
133041 
133042 
133043 
133044 
133045 
133046 
133047 
133048 
133049 
133050 
F-Nr. 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
175 
176 
177 
178 
179 
mg/kg narasin 
17,54 
19,86 
19,66 
17,69 
19,12 
18,81 
18,45 
18,54 
19,68 
19,77 
41,66 
39,56 
39,82 
42,28 
42,88 
40,45 
42,39 
42,50 
41,83 
42,19 
68,42 
63,46 
65,68 
63,35 
67,46 
63,00 
63,20 
63,27 
65,32 
64,33 
114,57 
113,86 
113,94 
117,27 
114,12 
113,85 
114,71 
113,86 
116,47 
114,99 
Average 
18,91 
41,56 
64,75 
114,76 
s 
0,85 
1,18 
1,93 
1,20 
CV% 
i. 
4,51 
2,84 
2,98 
1,04 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Homogeneity test collaborative study 
Additive : Narasin 
Product : Premixture: 
Date of determination : 
Sample 
1605 
1605 
1605 
1606 
1606 
1606 
1607 
1607 
1607 
1608 
1608 
1608 
1609 
1610 
1611 
1612 
1613 
1614 
Homogeneity 0 K 
Criterion : C V ^ ^ = < 7% 
Average 
SD (between samples) 
CV (between samples) 
Grubb's test, single lower 
Grubb's test, single upper 
Grubb's test, double lower 
Grubb's test, rlnuble upper 
1,2% 
October 23th, 2000 
Content 
% 
1,13 
1,16 
1,20 
1,29 
1,23 
1,29 
1,18 
1,12 
1,18 
1,27 
1,20 
1,30 
1,17 
1,14 
1,21 
1,13 
1,24 
1,28 
Duplicate 
average 
% 
1,16 
1,27 
1,16 
1,26 
1,17 
1,14 
1,21 
1,13 
1,24 
1,28 
1,2 
0,056 
4,7 
1,279 
1,386 
0,6047 
0,5310 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
Repeatability 
SD (within samples) 
CV (within samplesi 
(Sdr) 
(CV (%)) 
0,046 
3,9 
12-6-2001 
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APPENDIX 3 
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APPENDIX 4 
Narasin reference standard profile 
Eli Lilly and Company Limited 
Speke Operations 
Fleming Road 
Speke 
Liverpool L24 9LN 
UK 
January 17th 2001 
The following has been extracted from the current Lilly reference standard profile 
document for Narasin : 
* Effective Date: November 22, 2000 Compound: 079891 
* Supersedes: March 28,2000 Revision: 21 
Expiry Date: March 28, 2001 
Name: Narasin 
Lot Number: RS0302 
Defined Potency: 963 meg microbiological activity per mg on an 'as is' basis; 
85.4% factor A, 1.9% factor D, and 0.7% factor I on an 'as is' basis. 
Handling: Please refer to current MSDS for caution and handling information. 
Storage: 125 mg quantities in heat sealed amber glass ampoules with argon 
overlay at freezer temperature, -10° to -25°C. 
D. P. Towell 
Compliance Team 
Answers That Matte' 
APPENDIX 5 
Table with results, questionnaire (page 1) and chromatograms 
of partner 11 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
9-26.April, 2001 
I NARASIN 
Sample code 
113373 
113383 
113386 
113400 
113425 
113441 
113447 
113464 
113477 
113479 
Unit 
Result 
(mg/kg) 
20.6 
61.9 
ND 
67.5 
111.6 
18.5 
ND 
102.6 
43.1 
42.9 
Unit 
Sample 
Premixture 
Result 1 
(mg/kg) 
11402 
Result 2 
(mg/kg) 
10708 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 - Questionnaire 
Date(s) of analysis: 2 / 4 dÀ-. j(totkf......Â?.<?/... 
Chromatographic conditions: 
• Column: 
• jï(As described in the method 
• G Other: 
• Mobile phase: 
• ^ A s described in the method 
• G Other: ^ ., 
• Flovwate: ,.ÛA.è... ml/min 
• Injection volume: .IQO....\i\ 
Chromatograms: Please include representative chromatograms nf; 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D /1 peak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: /C'A. % 
• Single /duplicate determinations: G single ^duplicate 
• If duplicate, please give both percentages: //?&. % and 9.1:. % 
• Spiking level: .J.<2.... mg/kg 
CLASS-LC10 Ver.=1.63 SYS = 1 REPORT.NO=61 DATA-NA250406.KOI 01/04/25 14:30:37 
Sample 
ID 
Sample Amount 
Type 
Detector 
Operator 
Method Name 
premix b 
0.2107 
Unknown 
SPD-MlOAvp 
lju 
NARASIN.MET 
M 
Chromatogram 
mAbs 
*** Peak Report *** 
PKNO ChNO TIME AREA MK 
1 1 22.053 34617 V 
PURITY.UP PURITY.DOWN IDNO CONC 
0.9987(0.9488) 0.9994(0.9688) 1 10708.1250 
34617 10708.1250 
81 - 1/1 01/04/26 09:52:03 
: L A S S - L C 1 0 V e r . = 1 . 6 3 SYS=1 REPORT.NO=89 DATA-NA250412.KOI 0 1 / 0 4 / 2 5 2 0 : 4 9 : 3 8 
Sample 
:D 
Sample Amount 
^ype 
ï e t e c t o r 
o p e r a t o r 
le t hod Name 
113479 b 
5 .0273 
Unknown 
SPD-MlOAvp 
l j u 
NARASIN.MET 
II 
'** Chromatogram *** 
mAbs 
** Peak Report *** 
•KNO ChNO TIME AREA 
1
 1 21.784 32910 
MK PURITY.UP PURITY.DOWN IDNO CONC 
0.9975(0.9233) 0.9991(0.9685) 1 42.8736 
32910 42.8736 
89 1/1 01/04/26 09:53:25 
:LASS-LC10 Ver.=1.63 SYS-1 REPORT.N0=17 DATA=NA0904A9.K01 01/04/09 18:43:37 
Sample 
ID 
Sample Amount 
Type 
Detector 
Operator 
Method Name 
113386 b 
nara09 
1 
Unknown 
SPD-M10Avp 
lju 
NARASIN.MET 
*** Chromatogram *** 
mAbs 
*** Peak Report *** 
! ! No Identified Peak ! 
17 - 1/1 01/04/09 19:13:44 
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Annex 2 
CAN FAS 
: Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
I NARASIN 
Sample code 
133375 
133377 
133399 
133407 
133432 
133450 
133462 
133486 
133487 
133500 
Unit 
Result 
(mg/kg) 
64,9 
114,1 
42,2 
18,5 
66,4 
17,9 
<0,5 
<0,5 
43,6 
112,6 
Unit 
Sample 
Premixture 
Result 1 
(mg/kg) 
11402 
Result 2 
(mg/kg) 
11520 
3 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 • NARASIN 
Annex 4 • Questionnaire 
Datefs) of analysis: • 
Chromatographic conditions; 
• Column: 
• W A S described in the method 
• 0 Other: 
• Mobile phase: 
•^^ATdescribed In the mathod 
• a Other: 
• Flow-rate: ..r.*..3Z..... mtrtnln 
• Injection volume:"tf/OCuI 
Chrpmatopr^mi; P1—• »nfthide rcDre«cntatfaa chromrto«>ama oft 
• Blind positive feed samples X 
• Blind blank feed sample / 
• Premixture 7 
Please indicate the narasin factor A peak (and the factor D/lpeak, see Aram51 with m mvw 
Recovery,rnmfti'
 rt^ * 
. Percerrtaferecovery:??A 
• Single / duplicate determinations: o sirigte^uplicate 
• If duplicate, please five both percentages^;-- * «nd ....'1% 
Spiking level: S.U.... mg/kg ' ' * • 
Analyxwd: Mar 1, 2001 14,43 Reported; Mar 1, 2001 15:06 
Method Title : 
Method t P0LY1 
Sample i T 750a>10000 
1.B00 
«U 
e. 008 
Dat« Fil« t POLY1853.RU 
UNK - I n j 1 V i a l N o . « 1 
C h a n n e l : 1 
Ve>l * 100 u l 
Channwl 1 
• 0 . 1 1 1 1 1 r—-
B.BB S.BB 
• | W « f « I ^ M M ^ A ^ l 
1B.BB is .ea 
m i n u t a « 
C3> 
— i n 
20.BÜ 2 3 . BB 
Channwl 1 
Peak Quantitation ; HEIGHT 
Calculation M«thod : EXT-STD 
Sample Amount : 1.000 
Seal« Faetorl ; 1.000 
Kn RT NAME HEIGHT mg/kg R-FACTOR RRT BC 
"2* 2^19.96 Naraein 798 114.305 1.431C-01 18.94 BS 
TOTAL ^'799 114.305
 y f / ^ fy f 
Peak Rejection Level : 5 
Armlyiced: Fob 23, 2001 9îl6 
Mot hod TltU Î 
Method ; P0LY1 
Sarr.pl« j F 762 
Y 3 3 9éL 
1 . Q B 0 T 
n U 
H. Beer 
- e . m 
, 
R e p o r t e d : Fe»b 2 3 , 2001 11 ; 10 
/ * . - . 
Dat« Filo i POLY1844.RW Ch«nn«l : 1 
UNK - Tnj 1 Vi*l No. « 4 Vol * 100 ul 
Channel 1 
T" 
6£Cd blcuJè 
* « 
• M 
Hfr - - .-« . . . r • • » . « ! i - « ^ — i i _ L | _ M [ - . n 
—i 1 r - | 
e.ea 5.00 ie.ee is.ee 
minutes 
1 H 
2e.ee 23.ee 
Chann«! 1 
P*«U U u » n t i t « t i o n : HEIQHT 
C a l c u l a t i o n MwUiod '. EXT-OTD 
s
* m p i * Amount s 1 . 0 0 0 
S c * l o F * c t o r l : 1 . 0 0 0 
NO R I • NAME HEIGHT 
3
 1 3 . 2 1 Montna in 82 
mfl/kfl .R-FACTOR RRT BC 
USßf i 4 . 1 7 0 E - Û 2 1 2 . 9 9 BB 
TOTAL 
"•*»< R » 3 » « t i o n L-w-1 J B 
S2 1 . 3 5 5 
^53 Vf2/f&~2 
Analysed s M*r 12, 200.1. 13:56 Reported: Mar 12, 2001 14:43 
Method Tltli 
Method 
Sample 
1.B00 
nV 
B.006 
'8.111 
8.08 
P0LY1 Dat* File ; POLY18Ö9.RW 
Hlind«>50Rec. UNK - Inj 1 Vial No. 
Channel 1 
8 
I 
«H 
8 
~f 
5.08 iB.ee is.eu 
ninuis« 
Channel : 1 
Vol - 100 ul 
® 
2e.ee Z3.ee 
Channel 1 
Peak Quantitation : HEIGHT 
Calculation Method : EXT-STD 
Sample Amount : 1.000 
Su«le Factor! i 1.000 
NO 
3 
RT 
la.ta 
NAME 
Naraein 
HEIGHT 
658 
ma/kfl 
97.404 
R-FACTOR 
1.476E-01 
RRT 
19.66 
BC 
0B 
TOTAL 
Peak Hejaction Level : 5 
66S 97 .404 
&€*,**"/ 9&V'/ 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
>L 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
04.18.01 
I NARASIN 
Sample code 
233410 
233414 
233416 
233427 
233434 
233453 
233463 
233467 
233469 
233492 
Unit 
Result 
(mg/kg) 
19,3 
<2 
<2 
44,8 
69,1 
64,1 
18,3 
117 
119 
45,4 
Unit 
Sample 
Premixture 
Result 1 
(mg/kg) 
10420 
Result 2 
(mg/kg) 
10500 
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Annex 2 
c CAN FAS 
: Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY 
Date of analysis: 6-7/03/2001 
e-mail: 
fax: 
telephone: 
Analyte: [ NARASIN 
Sample code 
243390 
243409 
243420 
243421 
243435 
243457 
243474 
243483 
243484 
243501 
Unit 
Result 
(mg/kg) 
0 
20,1 
113,6 
41,1 
63,3 
16,4 
67,9 
112,9 
41,6 
I o 
Unit 
Sample 
Premixture 
Result 1 
(mg/kg) 
5244 
Result 2 
(mg/kg) 
6634 
CANFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 - NARASIN 
Annex 4 - Questionnaire 
«L 
Date(s) of analysis: f?..:J. Ü.S.r.frk Z&P.J... 
Chromatographic conditions: 
• Column: 
• D As described in the method 
y'Other: äfh.tt.&O. fr.lf. $.h...,.(z*?..?..$;.t.l\ 
• Mobile phase: 
• jzfks described in the method 
• a Other: 
• Flows-ate :.... /?.».?. ml/min 
• Injection volume: .4£f?....ui 
Chromatograms: Please include representative chromatograms
 fff; 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate tire narasin factor A peak (and the factor D/1 peak, see Annex 5) with an arrow 
Recovery results: •* 
• Percentage recovery: % 
• Single / duplicate determinations: D single G duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mg/kg 
* IAJ«. fc-ev -f»s*A*e.e/ S.'n^/g- eJt Te.*** l* j T / o ^ s o / +-ctjJ Sét^blti 
L<^eJt 4 : r / w i s /*=<? =£> ^ « C J D V * *- • / : 10. £. "/{ I . - . / 
0,0a 
0,04 
0,O3\ 
0 , 0 » 
0,01 
0.0O+ 
Peak Name 
Retention Time 
^ • a ^ °( a y**4 pos:*'** -he^ Sà^j.lc 
c:\elass-vp\chrom\ion07c07, Channel A 
^A 
^v^A J\ U~" 
10 
Minutes 
KJ.05 
J0.04 
k),03 
te A«'*«;~ 4 
KJ.02 
k),oi 
•0,00 
SA HP CE COO&-
e ^ ^ ö l i i l / o ^ r j l ^ v O 
'T 
/ o. Uà^h •£*</ j i u ^ l c 
i 4 3-To 4, 
c:\ciass-vp\chrom\ion07c15, Channel A 
0,05 
0,0» 
V 
o 
0,05 
0,04 
0.03 
Minutes 
V 
o 
I 
t 
L~^*n>*"** 4 * U^4 /~*/k'~ £•*"&>" 
c:Vclas8-vp\chrom\lon07c20, Channel A 
0.05H 
O.OM 
Peak Name 
Retention Time 
0,034 
0 ,0» 
0.01H 
O.OOJ 
°Ji, 
k),05 
K».04 
K>,03 
k),02 
K>.01 
lo.oo 
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Annex 2 
r CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as.E^ed additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLI 
04/04/2001 
I 
LABORATI\ 
NARASIN 
IE STUDY 
e-mail: 
fax: 
telephone: 
Sample code 
263412 
263419 
263424 
263449 
263452 
263455 
263465 
263470 
263493 
263502 
Unit 
Result 
(mg/kg) 
33,6 
64,7 
63,1 
2,8 
42,5 
103,8 
17,9 
0,6 
103,7 
20,4 
Sample 
Unit 
Premixture 
Result 1 
(mg/kg) 
8212 
Result 2 
(mg/kg) 
10063 
aJ 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 - Questionnaire 
± 
of analysis: ....?..^/..?..tt..|?.QOi Date(s) of analysis 
Chromatographic conditions: 
• Column: 
• o As described in the method 
. «Other: .9P£. . ^ I . ^ f c . 
• Mobile phase: 
• ISKÂS described in the method 
• G Other: 
• Flow-rate:. .<?. : S ml/min 
• Injection volume: !.9.9....\A 
Ctirnmatograms? p l e a s B delude representative chromatoerams of: 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/1 peak, see Annex 5) with an arrow 
Rernvery results: 
• Percentage recovery: .J.?.. % 
• Single / duplicate determinations: o single Dvdûplicate 
• If duplicate, please give both percentages: Q.\.% and " . £ : % 
• Spiking level: ..£1... mg/kg 
Software V e r s i o n : 4.1<2F12> 
jDate: 0 5 / 0 4 / 0 1 16:21 
jSample Name : Premix 1 
'Data F i l e : C:\TC4\CANFAS\NARASIN\LIN_AN~1\DATA019.RAW 
^Sequence F i l e : C:\TC4\CANFAS\NARASIN\LIN_AN~1\NARASIN1.SEQ 
I n s t r u m e n t : BOX_2 Rack /Via l : 0/0 O p e r a t o r : 
Sample Amount : 1.0000 D i l u t i o n Fac to r 
Date : 04 /04 /01 19:07 
Cyc l e : 19 Channel 
1.00 
.5 2o-q 
•K
 1 c 
m TU 
8 12 14 
< 
i i | [ i i i | i i i i | i i i i | i i i i | i i i i | i i n | M i i | i i i i [ i i M | i i i i | i i i i | i i i i i i i i i | i i i i | 
- 10 " " •*•* '" J- ' I 
Time [min] 16 18 
DEFAULT REPORT 
P e a k Time 
#
 [min] 
Area Height Area Norm. Area BL Area/Height 
[uV] [%] [%] [s] 
16.808 
17.825 
883397.00 21221.76 99.86 99.86 BE 41.63 
1265.00 136.14 0.14 0.14 EB 9.29 
884662.00 21357.91 100.00 100.00 
-,
 Ssing Component Report 
-omponent Expected Retention (Calibration File) 
All components were found 
Software Version: 4.1<2F12> 
Date: 05/04/01 16:22 
Sample Name 
Data File 
Sequence File 
Instrument 
Sample Amount 
263449 
C:\TC4\CANFAS\NARASIN\LIN_AN~1\DATA036.RAW 
C:\TC4\CANFAS\NARASIN\LIN_AN~1\NARASIN1.SEQ 
BOX_2 Rack/Vial: 0/0 Operator: 
: 1.0000 Dilution Factor 
Date: 05/04/01 00: 
Cycle: 36 Channe 
1.00 
-L 
400-= 
| 300-=J 
200-= 
100-= 
T T T T i T T T T 
|||||IIN|IIII|IIII|MII|IIII|III 
I I I ! I I 
t/1 < 
CE 
< 
CL 
I 
! 
T T 
l>ll|IIM|llll|llll|llll|llll|llll|llll|IIM[lll 
10 
Time [min] 
12 14 16 18 
DEFAULT REPORT 
Peak Time 
# [min] 
Area 
[uV-s] 
Height 
[uV] 
Area 
[%] 
Norm. 
[%: 
Area BL A r e a / H e i g h t 
[s] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
15.922 
16.181 
16.478 
16.725 
16.900 
17.117 
17.390 
17.658 
17.918 
1969.00 
2245.50 
5056.10 
15459.80 
22251.20 
10434.80 
4584.50 
2287.60 
1006.00 
221.61 
229.52 
519.31 
1199.28 
1424.80 
963.20 
426.08 
247.48 
138.96 
3.02 
3.44 
7.74 
23.68 
34.08 
15.98 
7.02 
3.50 
1.54 
3.02 
3.44 
7.74 
23.68 
34.08 
15.98 
7.02 
3.50 
1.54 
*BB 
BV 
W 
VV 
VV 
VV 
-.vv 
'VB 
*BB 
8.88 
9.78 
9.74 
12.89 
15.62 
10.83 
10.76 
9.24 
7.24 
65294.50 5370.24 100.00 100.00 
Missing Component Report 
Component Expected Retention (Calibration File) 
All components were found 
Software Version: 4.1<2F12> 
°ate: 05/04/01 16:22 
Sample Name 
Data File 
Sequence File: 
ïnstrument : 
Sample Amount 
263465 
C:\TC4\CANFAS\NARASIN\LIN_AN~1\DATA047.RAW 
C:\TC4\CANFAS\NARASIN\LIN_AN~1\NARASIN1.SEQ 
B0X_2 Rack/Vial: 0/0 Operator: 
: 1.0000 Dilution Factor 
Date: 05/04/01 04:45 
Cycle: 47 Channel 
1.00 
Oi 
*-; CO 
m 
ao 
to cö r^." 
ce «-3 
^ 
ni|iiii|iiii|i 
10 
Time [min] 
12 14 16 
i | ini|n 
18 
DEFAULT REPORT 
Peak Time 
[min] 
Area 
[jiV-s] 
Height Area Norm. Area BL Area/Height 
[pV] [%] t%] [s] 
1 
2 
3 
16, 
16. 
17. 
.120 
,852 
814 
2889. 
359897. 
1832. 
.13 
,87 
00 
275, 
8988. 
200. 
.19 
,04 
,23 
0, 
98. 
0. 
.79 
.71 
,50 ' 
0, 
98. 
0. 
.79 
.71 
,50 
BV 
VE 
EB 
10, 
40. 
9. 
.50 
,04 
,15 
364619.00 9463.45 100.00 100.00 
1ssing Component Report 
Component Expected Retention (Calibration File) 
All components were found 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person : 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
23-27.04.01 
I 
Sample code 
293384 
293426 
293431 
293445 
293454 
293460 
293471 
293489 
293490 
293499 
Unit 
Sample 
Premixture 
NARASIN 
Unit 
• 
Result 1 
(mg/kg) 
12800 
e-mail: 
fax: 
telephone: 
I 
Result 
(mg/kg) 
0 
16,96 
15,87 
44,26 
119,5 
68,1 
45,88 
0 
65,5 
114,4 
Result 2 
(mg/kg) 
13060 
CANFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 - NARASIN 
Annex 4 • Questionnaire 
& 
*L 
Date(s) of analysis: .? 2> . - .£ . iL . A f ^ L * ? ! ? * ? . . 
Chromatographic conditions: 
• Column: 
• D As described in the method 
. & other: £&£*- . fè*.fô- Q<S ^^.^Q.(X?]Or?.,A.u.rr>.. 
• Mobile phase: 
• ft As described in the method 
• D Other: 
• Flow-rate: Ç?fâ.... ml/min 
• Injection volume: .."3DQ.ul 
Chromatograms: Please include representative chromatoyram« «f 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/lpeak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: KX}B% 
• Single /duplicate determinations: # single a duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: ...5Q... mgAg 
SAMPLE 
Sample Name: PM I Dil 1/50 
Vial: 31 
injection«: 1 
Injection Volume: 200,00 uf 
Project Name: Narasin_CANFAS 
INFORMATION 
Processing Method: Nar24Ap 
Run Time: 20,0 Minutes 
Proc. Chnl. Descr.: PDA 600,0 nm 
Auto-Scaled Chromatogram 
- i — i — i — i — i — i — i — i — i — i — i — < — i — ' — ' — • — i — ' ' ' i—<~ 
2,00 4,00 6,00 8,00 10,00 12.00 
Mnutet 
T ' ' r I 1 1—1 1—1 , r-^  
14.00 16,00 18.00 20,00 
Peak Results 
1 
' 
Nanv 
Nar 
m 
16.189 
Area 
51704 
Height 
1248 
Amount Unfa 
1,280 ug/lrt 
Result :mg/kgnarasin 
I O O X A X D 
C = -
w 
A • amount (ug/ml) 
D -dilution factor 
w-weight 
C \Z8CO mo/kg narasin 
TbemikW ^ e. 
(a: 
SAMPLE 
Sample Name: 384 
Vial: 108 
Injection*: 1 
Injection Volume: 200,00 l i 
Project Nane: NaraslnjUAM-Aü 
INFORMATION 
Processing Method: Nar area 11 04 
Run Time: 28,0 Minutes 
Proc. Chnl. Descr.: PDA 600,0 nm 
Auto-Scaled Chromatogram 
< 
0,000-
,—|—i—,—I—r—I—I—I—I—I—1—I—I—I—I—1—I—I—1—1—I ' I—I—I—'—1—I—I—1—I—1—I—1—1—1—I—I—1—I I I I—1—I—I—I—I—I—r—T— 
2.00 4,00 6,00 8,00 10,00 12,00 14.00 16,00 18,00 20,00 22,00 24,00 26,00 28,00 
Minute« 
Peak Results 
1 
Nam 
Nar 
RT 
22,859 
Area Height Amount Unto 
Result : mg/kg narasin 
c=. 
100 x A x D 
w 
A - amount (ug/ml) 
D- dilution factor 
w-weight 
.mg/kg narasin 
"Bitnet b^nl^- ^aaA Qaro^l^ 
(îa 
SAMPLE 
Sample Name-
Vial: 
426 
35 
Injection* 1 
Injection Volume: 200,00 li 
Project Name: Narasin_CANFAS 
I N F O R M A T I O N 
Processing Method: Nar 24 Ap 
Run Time: 22,0 Minutes 
Proc. Chnl. Descr.: PDA 600,0 nm 
Auto-Scaled Chromatogram 
0,005-
0,004 
0,003 
0.002W 
; 
0,001-
0,000- J\~-— T — T — , — i — i I i i ' I 
2,00 4,00 6.00 
-i—|—i—i—i—|—i—i—i—i—i—i—i—r 
8,00 10,00 12.00 14,00 16,00 
Mnutes 
18,00 20,00 22,00 
Peak Remits 
Name! RT 
1 Nar 18,540 
Area 
68211 
Height Amount 
1183 1,6 
Unit» 
ug/rri 
Result :mg/kgnarasin 
I O O X A X D 
C = — — 
w 
A-amount (ug/ml) 
D - dilution fector 
w-weight 
J 6 . 9 & mg/Kg narasin 
t;^ p f^e ^ ^ ^ 
05/04 'Ol 10:1« . . . . _ „ 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 • Questionnaire 
xL 
Date(s) of analysis: ....&.3}.J.&GJC><4. 
Chromatographic eonditiona: 
• Column: 
• D As described in the method 
. pother: ,.„>£.Ca.«ttcub*E. G.Aß. ^.fa^kie..******. 
• Mobile phase: 
• / ^ A s described in the method 
• D Other: 
» riovwote: ..Ä?.*3^.... m|/min 
• Injection volume: ^ ioÄ..pl 
fthmmatftgrainc; Ptoai« include representative fthrnmatnprarnf „ft 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Phase ihchatf the narasfo factor A peak (and the facto. D/I peak, see Annex 5) with an arrow 
Bftrinvffry results: 
• Percentage recovery: rf.S. % 
m Single/duplicate determinations: Krfsinglc D duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: .$.%*.. mg/kg 
OV04 'Ol 15:24 
• 3.80-1 
3.60-
3.40-
3.20-
3.00-
2.80-
2.00-
2.4t 
130-
6 2.00-
1.B0-
0.4&J 
aaoJ 
O.Ofrl. 
QKx^ck fo\iGUA.tL rH 
1017 
ek <G «bocVr) \>le. 
^ ^ v v J ^ W ^ r t A ^ v A V v w b ^ v / i r/A/w«'»^*'A\A/\^-'^X«v-\^^ 
2.00 4.00 6.00 8.00 
0 5 / 0 4 '01 . 15:24 
3.80-
3.60-
3.40-
3.20H 
là 018 
a.ooi 
2.«H 
2.60 
2.4(H 
'xao4 
zotH 
1.BJH 
1.NH 
1>KH 
•I.2H 
low 
0.I0H 
3634/28 3 o' 
IfflUl 
4.80-
4.4(H 
4-2W 
4.0&J 
3*H 
SRTM 
3.40J 
t L20H 
E8.WH 
2.80-
2.00^ 
2.4* 
%30-
2 .0 * 
I 
1.8* 
1.6&I 
1-4* 
^ i' - e . YVV.V >* ooT< 
$*} 
jJöwffc^ * A 
^ _ ^ r — r x r ^ S S ' 24!oo ' âojoô ' Woo 30.C 
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Annex 2 
CANFAS 
: 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and MtiDI'otics.H?®.d..?.?.£®®f?.a^.V.ve5 (SMT4-CT98-2216) 
Subtitle: Task 4 COLLABORATIVE STUDY 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
I 
l 
20.02.0 
I 
Sample code 
313376 
313393 
313397 
313403 
313418 
313437 
313439 
313461 
313473 
313482 
Unit 
Sample 
^remixture _ _ 
1 
e-mail: 
fax: 
telephone: 
NARASIN | 
Uni 
Result 
t (mg/kg) 
17,7 
111,9 
109,3 
41,2 
64,1 
66,4 
18,0 
0 
40,4 
o 
Result 1 
(mg/kg) 
12102 
Result 2 
(mg/kg) 
11646 
CANFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 • NARASIN 
Annex 4 - Questionnaire 
•i,. 
Date(s) of analysis: ."?.£..-...$£...?. 2.GSJ 
Chromatographic conditions; 
• Column: 
• 0 As described in the method 
• G Other: 
• Mobile phase: 
• # As described in the method 
• D Other: 
• Flowf ate: Q.y$ ml/min 
• Injection volume: ...!£.«..ul 
Chromatograms: Please include representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/1 peak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: \Ç>$à% 
• Single / duplicate determinations: o single B duplicate 
• If duplicate, please give both percentages: % £ . % and M , à % 
• Spiking level: ...B.Q.... rng/kg 
Software Version 
Sample Name 
Instrument Name 
Rack/Vial 
Sample Amount 
Cycle 
: 6.1.1.0.0:K20 
blan. ,-1 (3* 
HPLC-1 
0/0 
1.000000 
6 
Date 
, Data Acquisition Time 
W a J c Channel 
Operator 
Dilution Factor 
2/21/01 8:12:03 AM 
2/20/01 5:01:18 PM 
A 
1.000000 
Result File : \\ 004s\TCDATA\.. Residue\HPLC-1\narasin\200201-006-20010221-081155.rst 
Sequence File : \\ 004s\TCdata\ Residue\HPLC-1\narasin\narasin200201.seq 
Page 1 of 1 
f -1 
1 0 — 
10 12 14 16 
Time [min] 
lllljlllljlllljlllljl 
18 20 22 
to 5 < 
z 
24 26 
narasin 
ÏÏ[TÏÏTJTTÏÏ] 
28 
Peak Time Component Area Height Area Norm Area BL Area/Height 
# fminl Nam* fuV-sl fuVI [%] f%J ™ 
1 27.40 narasin 
2 28.42 
794.01 39.82 19.17 
3347.31 78.45 80.83 
Wssing Component Report 
Component Expected Retention (Calibration File) 
AJI components were found 
19.17 BV 
80.83 VB 
19.9375 
42.6675 
4141.32 118.28 100.00 100.00 
%SIOA*CO\JOUI, 
Page 1 of 1 
Software Version 
Sample Name 
Instrument Name 
Rack/Vial 
Sample Amount 
Cycle 
: 6.1.1.0.0:K20 
: 30258-a (3*' 
: HPLC-1 
: 0/0 
: 1.000000 
: 9 
Result File : V 004s\TCDATA\ 
Sequence File : v :004s\TCdata\ 
I tZM% 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
2/21/01 8:12:06 AM 
2/20/01 6:36:13 PM 
/* 
1.000UOO 
Residue\HPLC-1\narasin\200201-009-20010221-081155.rst 
Residue\HPLC-1\narasin\narasin200201.seq 
@ 
51 
E 
«L CM 
I 
iiii|iiiiliiiiliiiiii!ii|im TTTTT 
10 12 14 16 18 20 22 
ÏÏÏÏÏÏ1 
24 
Time [min] 
narasin 
26 
l|l!ll|llll 
28 
Peak Time Component 
# [min] Name 
1 24.23 
2 28.25 
3 29.18 
narasin 
Area 
[uV-s] 
381402.50 
16810.92 
5679.08 
Height 
[pV] 
10748.73 
252.80 
136.21 
Area 
[%] 
94.43 
4.16 
1.41 
Norm. Area BL Area/Height 
[%] [s] 
403892.50 11137.74 100.00 
h iss ing Component Report 
Component Expected Retention (Calibration File) 
94.43 
4.16 
1.41 
100.00 
BB 
BV 
VB 
35.4835 
66.4990 
41.6928 
All components were found 
Software Version 
Sample Name 
Instrument Name 
Rack/Vial 
Sample Amount 
Cycle 
: 6.1.1.0.0:K20 
30266 (3*' 
HPLC-1 
0/0 
1.000000 
20 
?'MJ? 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
2/21/01 8:12:16 AM 
2/21/01 12:24:23 AM 
A 
l.UUUUUO 
Result File : \Y ,J04s\TCDATA\ Residue\HPLC-1\narasin\200201-020-20010221-081156.rst 
Sequence File : V .004s\TCdata\ • Residue\HPLC-1\narasin\narasin200201.seq 
Page 1 of 1 
dp 
narasin 
peak Time Component Area 
# [min] Name [uVs] 
Height Area Norm. Area BL Area/Height 
ruVl r%l l%] M 
1 23.71 narasin 
2 27.87 
3 28.92 
341857.00 9510.46 95.70 
7624.24 172.14 2.13 
7740.26 155.57 2.17 
•wssing Component Report 
Component Expected Retention (Calibration File) 
All components were found 
95.70 BB 35.9454 
2.13 BV 44.2900 
2.17 VB 49.7529 
357221.50 9838.17 100.00 100.00 
VHCVUJUA %\, ly ^ 1 
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Table with results, questionnaire (page 1) and chromatograms 
of partner 32 
Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics usedI asJEeed addit ives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
323378 
323382 
323395 
323398 
323406 
323417 
323440 
323446 
323481 
323488 
NARASIN 
Unit 
negative 
negative 
34,90 
96,43 
35,74 
15,14 
55,96 
15,07 
93,04 
51,69] 
Result 
(m9/k9? 
negative 
negative 
34,89 
97,69 
35,85 
15,58 
56,69 
_15,_18 
93,49 
52,43 
Sample 
Unit 
Result 1 
(mg/kg) 
10041,48 
Result 2 
(mg/kg) 
10450,68 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 - Questionnaire 
Chromatographic conditions: 
• Column: 
• • As described in the method 
• X o t n e r : Waters Spherisorb, 5 um, S5 ODS 2, 250 mm X 4.6 mm 
• Mobile phase: 
• D As described in the method 
• X o t n e r : M e 0 H • Phosphate buffer ( 97+3) 
• Flow-rate: 1.0 ml/min 
• Injection volume: 100 ui 
Chromatoarams: Please include representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/l peak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: 82.3% 
• Single / duplicate determinations: D single ^ (duplicate 
• If duplicate, please give both percentages: 82.28% and 82.32% 
• Spiking level:.50 mg/kg 
Rie C:\HPCHEM\1\DATA\NARCANRDMABA005.D 
ode 323382/- 5.0005g 
»5 OPS 2. 4.6x250 mm. 
DAD1 A, Sig=600,4 Ref=410,20 (NARCANF\DMABA005.D) 
mAlH 
0 4 
-50 
-100 -i 
-150 H 
-200 H 
-250 
External Standard Report 
PM 
Sorted By Signal 
Calib. Data Modified : 3/16/0112:34:33 
Multiplier 1.0000 
Dilution 1.0000 
Signal 1: DAD1 A, Sig=600,4 Ref=410,20 
fcerrime Type Height Amt/Height Amount Grp Name 
Nn] [mAU] [ug/ml] 
7.356 MM 40.60791 6.01554e-2 2.44278 NAR A 
7.827 MM 5.72264e-15.18771e-2 2.96874e-2 NAR D+l 
T
«als : 2.47247 
ru
"ient 1 3/16/0112:42:57 PM 
O d i i i y i c i van is . «MS.WWU 
flection Date : 3/15/01 7:52:59 PM Seq. une : 5 
ample Name : 323382/ Vial: 10 
cq. Operator Inj: 1 
Inj Volume : 100 ul 
•cq. Method : C:\HPCHEM\1\METHODS\NARASIN .M 
ast changed : 3/15/01 7:50:24 PM by 
(modified after loading) 
»nalysis Method : C:\HPCHEM\1\METHODS\NARASIN .M 
ast changed : 3/16/01 12:39:21 PM by 
(modified after loading) 
& 
Waters Sp 
>$ 
3 OD 
«D 
-ma 
3ta File C:\HPCHEM\1\DATA\NARCANRDMABA008.D 
Code 323398 -5.0002g 
bampie name: oioo»o 
Injection Date : 3/15/01 8:27:14 PM 
Sample Name : 323398 
Acq. Operator 
Seq. Line : 8 
Vial: 13 
Inj: 1 
Inj Volume : 100 pi 
C:\HPCHEM\1\METHODS\NARASIN M 
: 3/15/01 8:24:38 PM by 
(modified after loading) 
Analysis Method : C:\HPCHEM\1\METHODS\NARASIN ,.M 
Last changed : 3/16/01 12:50:55 PM by 
(modified after loading) 
S5 OPS 2, 4.6 X 250 mm 
Acq. Method 
Last changed 
n 
External Standard Report 
Sorted By Signal 
Calib. Data Modified : 3/16/01 12:34:33 PM 
Multiplier 1.0000 
Dilution 1.0000 
Signal 1: DAD1 A, Sig=600,4 Ref=410,20 
RetTime Type Height Amt/Height Amount Grp Name 
[min] [mAU] [ug/ml] 
1 1 1 1 1_| 
7.401 MM 12.81608 5.90738e-2 7.57094e-1 NAR A 
7.814 - - - NARD+I 
Totals : 7.57094e-1 
trument 1 3/16/01 12:52:40 PM 
Pag€lof 2 
) File C:\HhnJlibM\1 \UA I AUNAKOMrvru^M/Aonu i^.u 
Code 323417-5.0010g 
Injection Date : 3/15/01 9:13:02 PM Seq. une : 12 
Sample Name : 323417 Vial: 17 
Acq. Operator : Inj: 1 
Inj Volume : 100 pi 
Acq. Method : C:\HPCHEM\1\METHODS\NARASIN, M 
Last changed : 3/15/01 9:10:26 PM by 
(modified after loading) 
Analysis Method : C:\HPCHEM\1\METHODS\NARASIN .M 
Last changed : 3/16/01 12:50:55 PM by 
(modified after loading) 
55 OPS 2.4.6 x 250 mm. 
® 
Waters Sp 
DAD1 A, Sig=600,4 Ref=410,20 (NARCANBDMABA012.D) 
m W i 3
 S . . . * • & 
•ft- mm 
External Standard Report 
Sorted By Signal 
palib. Data Modified : 3/16/0112:34:33 PM 
Multiplier 1.0000 
Dilution 1.0000 
s
'gnal 1: DAD1 A, Sig=600,4 Ref=410,20 
*etTime Type Height Amt/Height Amount Grp Name 
tolnj [mAU] [ug/ml] 
•^ H 1 1 1 H— ' 
7.419 - - - NARA 
7.814 - - - NARD+I 
T
°tals : 0.00000 
^ e n t 1 3/16/01 12:59:05 PM 
Pagdof 2 
pa n i e o . \ n r v / n t i » i i i i u n i n u i n i \ u n n i <w IWI« M * V 1 
Code premix - 1 0009g 
Injection Date : 3/15/0111:30:40 PM Seq. Une : 24 
Sample Name : Premix2 Vial : 29 
Acq. Operator : Inj : 1 
Inj Volume : 100 ui 
Acq. Method : C:\HPCHEM\1\METHODS\NARASIN ..M 
Last changed : 3/15/01 11:28:07 PM by, 
(modified after loading) 
Analysis Method : C : \ H P C H E M \ 1 \ M E T H O D S \ N A R A S I N J M 
Last changed : 3/16/01 2:58:34 PM by 
(modified after loading) 
S5 OPS 2, 4.6 x 250 mm. 
/VdvUrhV 
4, 
X-
Waters Sp 
DAD1 A, Sig=600,4 Ref=410,20 (NARCANF\DMABA024.D) 
mAU 
8 
- > — l — ' — ' — • " 
5 
44^ 
B mir 
External Standard Report 
Sorted By Signal 
Calib. Data Modified : 3/16/01 12:34:33 PM 
Multiplier 1.0000 
Dilution 1.0000 
Signal 1: DAD1 A, Sig=600,4 Ref=410,20 
RefTime Type Height Amt/Height Amount Grp Name 
[min] [mAU] [ug/ml] 
1 1 1 1 hi 
7.424 MM 17.62598 5.950506-2 1.04883 NAR A 
7.980 MM 2.09057e-1 0.00000 0.00000 NAR D+l 
KstrunT 
Totals: 1.04883 
ent 1 3/16/01 2:59:49 PM 
Page!of 2 
APPENDIX 5 
Table with results, questionnaire (page 1) and chromatograms 
of partner 33 
Annex 2 
CANFAS u 
Development and Validation of HPLC-methods for the officiafcontrolI of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: Task 4 CO 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
16-02-200 
I 
1 
Sample code 
333381 
333392 
333396 
333451 
333459 
333476 
333478 
333485 
333491 
333497 
Unit 
Sample 
Premixture 
LLABORATI VE STUDY 
e-mail: 
fax: 
telephone: 
I 
NARASIN | 
Unil 
Result 
(mg/kg) 
17,0 
38,7 
59,7 
16,4 
afwezig 
afwezig 
59,3 
105,5 
105,9 
39,7 
Result 1 I Result 2 
(mg/kg) (mg/kg) 
I 
8474 8501 
33 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 - Questionnaire 
Date(s) of analysis: Tlf./.M.JX/o 4, 
e*** 
Chromatographic conditions: 
• Column: 
• D As described in the method 
• /£ Other: tó^wwK...<?.&..£. $.Km....i$.. 
• Mobile phase: 
• lp(As described in the method 
• D Other: 
• Flow* ate : f?^. C ml/min 
• Injection volume: ..à..*-?...pi 
Chromatograms: Please include representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/1 peak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery: b.M.. % 
• Single/duplicate determinations: a single n duplicate 
• If duplicate, please give both percentages: 96 and % 
• Spiking level: ...a.D... mg/kg 
Sanple Set Narre N4R16 
User Name FVSA 
Current Date 16/02/01 
Current Time 12:37:52 
I'vUwu«. Ku*uu i; 
Auto-Scaled Chromatogram 
- i—i—i—|—i—i—i—i—i—i—r-
4,00 5,00 
Mnutes 
SampleName 0848/01 Vial 12 ejection 2 Channel 996 Date Acquired 16/02/01 11:46:00 
1of2 
Sanpie Set Name NAR16 
User Name FVSA 
•i. 
Current Date 16/02/01 
Current Time 12:37:15 
0,007-
Auto-Scaled Chromatogram 
iz***i 
- i — i — i — ) — r 
1.00 
- 1 1 — I I 1 1 1 j 1 1 1 1 1 1 1 ! 1 1 1 1 1 1 f " 
2,00 3,00 4,00 5,00 6,00 
Minutes 
SampteName 0850/01 Vial 10 hjection 1 Channel 996 Date Acquired 16/02/0111:14:24 
9.00 
1of2 
(S) 
Sanpte Set Narre NAR16 
User Name RVSA 
Current Date 16/02/01 
Current Tme 12:36:22 
0,003 
GP 3 1 3 ^ ? ^ 
Auto-Scaled Chromatogram 
4.00 5,00 
Mnutes 
SarrpleName 0841/01 Vial 3 hjection 1 Channel 996 Date Acquired 16/02/0110:00:32 
9,00 
1of2 
APPENDIX 5 ± 
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Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as E?®f!.Ädd't,veS (SMT4-CT98-2216) 
Subtitle: Task 4 COLLABORATIVE STUDY 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
09-04-2001 
| 
Sample code 
353374 
353380 
353387 
353405 
353408 
353422 
353438 
353444 
353466 
353468 
Unit 
Sample 
Premixture 
e-mail: 
fax: 
telephone: 
NARASIN | 
Unit 
Result 1 
(mg/kg) 
12036 
Result 
(mg/kg) 
44 
67 
<1 
116 
70 
42 
19 
< 1 
108 
18 
Result 2 
(mg/kg) 
12583 
i£~ 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 - Questionnaire 
Date(s) of analysis: . . . & . £ Ç K ' , . L . . 1 U X M
 4. 
Chromatographic conditions: 
• Column: 
• a As described in the method 
• GfOther: CÏHQ/^lph(^.SSj.(X^3.Ü...Üirx>.....LZXj....v 
• Mobile phase: 
• d^As described in the method 
• • Other: 
• Flow-rate: Sß^£eff?CimArm 
• Injection volume: JDO...]ä 
Chramatayramsr. Please include representative ehmtnatogram« aft 
• Bund positive feed samples 
• Blind blank feed sample 
• Prembrture 
Please Meats the narasin factor A peak (and the factor D//peak, see Annex 5) with an arrow 
Recovery results; 
• Percentage recovery:^k^% -^ 
• Single / duplicate determinations: Jf single^ duplicate 
• If duplicate, please give both percentages:Ç,6 % and <JS,3 X 
• Spiking level: . / £&. . . mg/kg 
Fax. 
Thank you for your cooperation f ® 
0.006 
0.005-
0.004 
r-
0.003 W"* 
e 8 
Minutes 
10 12 
-0.003 
14 
• \\Fs_ AVOL1\DATA\Elite_Admin\Projects\lonophor :y3ata\Narasin_010409bw 006, UV-D tecte 
BM. 
35", 
*t 
> 
0.035-
0.030-
0.025 
A 
V 
I I 
I I 
I ' 
i : 
i . - 1 
^A A— „ . I I , * •, ^ . y x i ^ M - n 
a 
Minutes 
10 12 
'-0.03S 
0.030 
•0.025 
a 
5 
14 
\\Fs_ \VOL1\DATA\Elite_Admin\Projects\lonophor \Data\Narasin_010409bw_015. UV-Detector 
zttuzB 
0.0475 • 
0.0400 
I i 
IA-WA 
® 
i - /I - T 
0.0475 
i I ' 
0.0450-j f ] 
I 
4? 0.0425 I ' 
/ ! r0.04S0 
; i 
I 
5 1
 ' ' ;-o.o42s 
ft«A^^.<w1>A»V>^W»rf^^^l«*vw*w*^*'>, 
I 
.-0.0400 
0.0S75 
1
 r 1 . r - -, L0.0375 
2 4 6 8 10
 1 2 u 
\\Fs_ )\VOL1\DATA\EI(te_Admin\PrpjBcts\/onophop ADate\NaraslnJM0409bw 023, UV-Detecto 
pre mrx 
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Annex 2 
CAN FAS ZI 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as JEeed 4^A*AY.ef..<SMT4"CT98"2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
11-12 april 2001 
NARASIN 
Sample code 
373389 
373391 
373404 
373423 
373429 
373433 
373458 
373472 
373475 
373480 
Unit 
Result 
(mg/kg) 
38,6 
17,3 
114,6 
-
64,8 
60,1 
40,7 
19,4 
102,0 
J 
Unit 
Sample 
Premixture 
Result 1 
(mg/kg) 
10038,5 
Result 2 
(mg/kg) 
11213,8 
-T 
CANFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 - NARASIN 
Annex 4 - Questionnaire 
i . 
Datds} of analysis: . . . J S J E S ? . . 
Chromatographic conditions: 
• Column: 
D As described in the method 
. Blähen .\^*Mfelb..&^.3^..Q*....^fett?..*. .!fck*tt$). 
• Mobile phase: ' 
• o^ts described in the method 
• a Other: 
• Flowfate: .CI.-3: ml/min 
• Injection volume: .W?P....ul 
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APPENDIX 5 ^ 
Table with results, questionnaire (page 1) and chromatograms 
of partner 41 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics usedI as Eeed additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
17.04.2001 
NAR AS IN 
Sample code 
413388 
413394 
413401 
413411 
413413 
413415 
413442 
413443 
413495 
413498 
Unit 
Result 
(mg/kg) 
20,5 
47,1 
20,4 
0 
113,6 
69,5 
114,7 
69,7 
0 
45,2 
Unit 
Sample 
Premixture 
Result 1 
(mg/kg) 
11007 
Result 2 
(mg/kg) 
11420 
<ïl 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - NARASIN 
Annex 4 - Questionnaire 
^ 
Date(s) of analysis: )ÄAÄ£?±..R?Ä. \2^A.Ä°.?± 
Chromatographic conditions: 
• Column: 
• K As described in the method 
• o Other: 
• Mobile phase: 
• Or As described in the method 
• D Other: 
• Flowfate:. .£/.. X ml/min 
• Injection volume: /x.£L.ul 
Chromatograms: Please include representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample 
• Premixture 
Please indicate the narasin factor A peak (and the factor D/Ipeak, see Annex 5) with an arrow 
Recovery results: 
• Percentage recovery:'.?./. % 
• Single / duplicate determinations: 0 single JK duplicate 
• If duplicate, please give both percentages:/^. % and/f?.?. % 
• Spiking level: . „ . . . mg/kg 
® 
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START 1 
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pfLeH \XTOQ.c: 
3 2 Q . G 9 7 
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CHROMATOPAC C-R3A 
?AMPLE NO 9 
FÎP0RT MO 5452 
F'KNO 
1 
TIME HIGHT MK IDMO 
20.66? 2530 
8G258ar 
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METHOD 
COMC 
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0 
3021 
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TOTAL 2530 109 
